Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Mullally

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Blood|November 12, 2010
Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cellsShilpee Dutt, Anupama Narla, Katherine Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint responseEdwin Chen, Jong Sook Ahn, Charlie E Massie, et al.
Cancer Cell|September 23, 2014
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDSRebekka K Schneider, Vera Ademà, Dirk Heckl, et al.
Blood Advances|October 13, 2020
Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsisJulie Ng, Fei Guo, Anna E Marneth, et al.
Haematologica|January 2, 2015
Role of the clathrin adaptor PICALM in normal hematopoiesis and polycythemia vera pathophysiologyYuichi Ishikawa, Manami Maeda, Mithun Pasham, et al.
Blood|August 30, 2011
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndromeMadhu S Kumar, Anupama Narla, Atsushi Nonami, et al.
Leukemia Research|October 6, 2020
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemiaJoan How, Orly Leiva, Thomas Bogue, et al.
Blood Advances|December 4, 2018
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapySuhu Liu, Anna E Marneth, Gabriela Alexe, et al.
Cancer Discovery|March 9, 2016
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic TransformationShannon Elf, Nouran S Abdelfattah, Edwin Chen, et al.
Nature Genetics|March 17, 2009
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasmsOuti Kilpivaara, Semanti Mukherjee, Alison M Schram, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Blood|November 12, 2010
Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cellsShilpee Dutt, Anupama Narla, Katherine Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint responseEdwin Chen, Jong Sook Ahn, Charlie E Massie, et al.
Cancer Cell|September 23, 2014
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDSRebekka K Schneider, Vera Ademà, Dirk Heckl, et al.
Blood Advances|October 13, 2020
Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsisJulie Ng, Fei Guo, Anna E Marneth, et al.
Haematologica|January 2, 2015
Role of the clathrin adaptor PICALM in normal hematopoiesis and polycythemia vera pathophysiologyYuichi Ishikawa, Manami Maeda, Mithun Pasham, et al.
Blood|August 30, 2011
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndromeMadhu S Kumar, Anupama Narla, Atsushi Nonami, et al.
Leukemia Research|October 6, 2020
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemiaJoan How, Orly Leiva, Thomas Bogue, et al.
Blood Advances|December 4, 2018
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapySuhu Liu, Anna E Marneth, Gabriela Alexe, et al.
Cancer Discovery|March 9, 2016
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic TransformationShannon Elf, Nouran S Abdelfattah, Edwin Chen, et al.
Nature Genetics|March 17, 2009
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasmsOuti Kilpivaara, Semanti Mukherjee, Alison M Schram, et al.
Pageof 7